Seroepidemiologic Studies
"Seroepidemiologic Studies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases.
Descriptor ID |
D016036
|
MeSH Number(s) |
E05.318.760.500.950 N05.715.360.775.175.800 N06.850.520.450.500.950
|
Concept/Terms |
Seroepidemiologic Studies- Seroepidemiologic Studies
- Studies, Seroepidemiologic
- Seroepidemiological Study
- Seroepidemiological Studies
- Studies, Seroepidemiological
- Study, Seroepidemiological
- Seroepidemiologic Study
- Study, Seroepidemiologic
|
Below are MeSH descriptors whose meaning is more general than "Seroepidemiologic Studies".
Below are MeSH descriptors whose meaning is more specific than "Seroepidemiologic Studies".
This graph shows the total number of publications written about "Seroepidemiologic Studies" by people in this website by year, and whether "Seroepidemiologic Studies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2002 | 0 | 2 | 2 |
2003 | 0 | 1 | 1 |
2004 | 0 | 9 | 9 |
2005 | 0 | 3 | 3 |
2006 | 0 | 6 | 6 |
2007 | 0 | 2 | 2 |
2008 | 0 | 5 | 5 |
2009 | 0 | 5 | 5 |
2010 | 0 | 4 | 4 |
2011 | 0 | 5 | 5 |
2012 | 0 | 3 | 3 |
2013 | 0 | 9 | 9 |
2014 | 0 | 5 | 5 |
2015 | 0 | 11 | 11 |
2016 | 1 | 12 | 13 |
2017 | 10 | 123 | 133 |
2018 | 7 | 121 | 128 |
2019 | 2 | 62 | 64 |
2020 | 9 | 126 | 135 |
2021 | 9 | 256 | 265 |
2022 | 0 | 4 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Seroepidemiologic Studies" by people in Profiles.
-
Seroprevalence of SARS-CoV-2 Among Workers in Northern Italy. Ann Work Expo Health. 2022 02 18; 66(2):224-232.
-
Sustained seroprevalence of SARS-CoV-2 antibodies one year after infection: one of the first COVID-19 cluster cases in Bosnia and Herzegovina. Bosn J Basic Med Sci. 2022 Feb 01; 22(1):147-152.
-
Prospective SARS-CoV-2 cohort study among primary health care providers during the second COVID-19 wave in Flanders, Belgium. Fam Pract. 2022 01 19; 39(1):92-98.
-
Performance Comparison of Five SARS-CoV-2 Antibody Assays for Seroprevalence Studies. Ann Lab Med. 2022 Jan 01; 42(1):71-78.
-
Antibodies to SARS-CoV-2 in dogs and cats, USA. Emerg Microbes Infect. 2021 Dec; 10(1):1669-1674.
-
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection. J Infect Dis. 2021 11 16; 224(9):1489-1499.
-
Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study. Int J Epidemiol. 2021 Nov 10; 50(5):1458-1472.
-
Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021. JAMA. 2021 10 12; 326(14):1436-1438.
-
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept. Am J Transplant. 2021 12; 21(12):4043-4051.
-
High rate of clinically unrecognized SARS-CoV-2 infections in pediatric palliative care patients. Eur J Pediatr. 2022 Feb; 181(2):847-851.